Biota Provides an Update on the Development of Laninamivir Octanoate

[GlobeNewswire] – ATLANTA — Biota Pharmaceuticals, Inc. (the Company) today announced that an interim update has been provided from the U.S. Department of Health and Human Services (HHS) and the Biomedical … more

View todays social media effects on BOTA

View the latest stocks trending across Twitter. Click to view dashboard

See who Biota is hiring next, click here to view